About QRL Bioscience
QRL Bioscience is a Healthcare company based in Ahmedabad (India) founded in 2021 by Kranti Vora, Senthil Natesan, and Sanjoy Bhagat. CRO focused on cancer cell based clinical trial services. QRL Bioscience has raised $341.58 thousand across 1 funding round from investors including Gujarat Venture Finance. Its Indian entity Qrl Bioscience Private Limited reported revenue of ₹21.5 Lakh. QRL Bioscience offers products and services including QRLBIO001, QRLBIO002, QRLBIO003, Cell Therapy Manufacturing, and Immunophenotyping of Cells. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.
Company details
QRL Bioscience cro focused on cancer cell based clinical trial services, focusing on providing healthcare solutions, biopharma outsourcing, cro, clinical development, full service, and oncology. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Ahmedabad, India
- Founders Kranti Vora, Senthil Natesan, Sanjoy Bhagat
- SectorsHealthcare
- Website qrlbioscience.com
- Social LinkedIn
- Legal Name Qrl Bioscience Private Limited
- Date of Incorporation 16 Apr, 2023
- Jurisdiction Gandhinagar, Gujarat, India
- Annual Revenue₹21.5 Lakh
FY 2025 · +10414% YoY
- Net Loss-₹29.9 Lakh
FY 2025 · -139% margin
- EBITDA-₹24.1 Lakh
FY 2025 · -112% margin
- Total Equity Funding$341.58K (USD)
in 1 rounds
- Latest Funding Round$341.58K (USD), Seed
Aug 2025
- Investors
Associated legal entities of QRL Bioscience
QRL Bioscience operates through Qrl Bioscience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Qrl Bioscience Private Limited CIN U72200GJ2023PTC140362 | Active | 16 Apr 2023 | Gandhinagar, Gujarat | ₹0.2 Cr | 5 | View details |
Products & Services of QRL Bioscience
QRL Bioscience offers a comprehensive portfolio of products and services, including QRLBIO001, QRLBIO002, QRLBIO003, Cell Therapy Manufacturing, and Immunophenotyping of Cells.
Autologous therapy for chronic non-healing wounds
Product for additional chronic conditions
Therapy targeting degenerative diseases
Manufacturing of cell-based therapeutic products
Analysis service for cell characteristics
Testing for cell-based immune responses
Funding Insights of QRL Bioscience
QRL Bioscience has successfully raised a total of $341.58K through 1 strategic funding round. The most recent funding activity was a Seed round of $341.58 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $341,583
- Total Rounds 1
- Last Round Seed — $341,583
- First Round $341,583
(Aug 2025)
- Investors Count 1
All 1 funding rounds of QRL Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $341,583 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in QRL Bioscience
QRL Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gujarat Venture Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in Indian startups across multiple sectors. | 1990 | gvfl.com | Ahmedabad, India |
Investor details for QRL Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Qrl Bioscience Private Limited (QRL Bioscience)
Qrl Bioscience Private Limited is the primary company behind QRL Bioscience. The board of Qrl Bioscience Private Limited currently have 5 directors; the longest-serving is Sanjoy, appointed in 2023. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjoy DIN 09034603 | Director | 16 Apr 2023 | 3 yrs 6 mo | Qrl Bioscience Private Limited |
| Senthilkumar Natesan DIN 07692514 | Director | 16 Apr 2023 | 3 yrs 6 mo | Qrl Bioscience Private Limited |
| Kranti Vora DIN 08161240 | Director | 16 Apr 2023 | 3 yrs 6 mo | Qrl Bioscience Private Limited |
| Mahavir Pratap Sharma DIN 01852846 | Director | 21 Jun 2024 | 2 yrs 4 mo | Qrl Bioscience Private Limited |
| Saurabh Rajan Nair DIN 10112215 | Nominee Director | 14 Jul 2025 | 1 yr 3 mo | Qrl Bioscience Private Limited |
People of QRL Bioscience
3 people are tracked at QRL Bioscience (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
Senthil Natesan | Co-Founder | Leadership |
Sanjoy Bhagat | Co-Founder | Leadership |
Complete people profiles for QRL Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of QRL Bioscience
Figures of Qrl Bioscience Private Limited, the primary company behind QRL Bioscience, for FY 2025. Revenue was ₹21.5 Lakh (+10414% year on year). Net loss was -₹29.9 Lakh (-139% margin). EBITDA was -₹24.1 Lakh (-112% margin).
- ₹21.5 LakhRevenue · FY 2025 · +10414% YoY
- -₹29.9 LakhNet loss · -139% margin
- -₹24.1 LakhEBITDA · -112% margin
- ₹27.5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Qrl Bioscience Private Limited are on its company page.
Detailed financial statements for QRL Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of QRL Bioscience
2 dated milestones of QRL Bioscience across 4 years, from founding to its latest funding, stage changes and deals.
- Founded QRL Bioscience is founded.
- Funding First funding round of $342K.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as QRL Bioscience (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about QRL Bioscience
QRL Bioscience was founded in 2021 and raised its 1st funding round 4 years after it was founded.
QRL Bioscience is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
QRL Bioscience is a funded company, having raised a total of $341.58K across 1 funding round to date. The company's 1st funding round was a Seed of $341.58K, raised on Aug 2025.
The primary company behind QRL Bioscience, Qrl Bioscience Private Limited, reported revenue of ₹21.5 Lakh for FY 2025, up 10414% year on year.
QRL Bioscience cro focused on cancer cell based clinical trial services, focusing on providing healthcare solutions, biopharma outsourcing, cro, clinical development, full service, and oncology. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
QRL Bioscience offers QRLBIO001, QRLBIO002, QRLBIO003, Cell Therapy Manufacturing, and 2 more products and services.
QRL Bioscience has 1 investor. Key investors include Gujarat Venture Finance.
QRL Bioscience operates through Qrl Bioscience Private Limited.
The legal entities of QRL Bioscience currently have 5 directors, including Sanjoy, Senthilkumar Natesan, Kranti Vora and others.